Philips Introduces the Futuristic BlueSeal Series with AI Enhancements
At the upcoming ITEM 2026 in Yokohama, Philips Japan will unveil its groundbreaking BlueSeal series. This new line integrates next-generation AI technology to improve workflow efficiencies and clinical performance in MRI diagnostics. These advancements come at a critical time when healthcare fields seek dependable and sustainable solutions.
Revolutionizing MRI Performance with Advanced Magnet Technology
Micro-Cooling Technology
The BlueSeal series is equipped with an innovative micro-cooling technology that enables superconductivity using just seven liters of liquid helium. This advancement reduces helium consumption to less than 0.5% of what traditional models require. With liquid helium tightly sealed within the system, the necessity for continuous refills is eliminated. This innovative approach allows rapid restoration to operational status in emergency scenarios, addressing current challenges linked to helium resource availability.
Efficient Shield Cryostat
Philips' Efficient Shield Cryostat further enhances clinical performance by minimizing metal within the magnet. This reduction limits thermal influx from gradient coils and mitigates eddy currents. As a result, high gradient performance is maintained during demanding imaging sessions, thus ensuring uniformity and stability of the magnetic field, vital for accurate image diagnostics.
AI-Driven Workflow Efficiency
SmartExam Automation
The BlueSeal series expands the capabilities of the SmartExam function, achieving automatic planning in 80% of imaging cases. This enhancement standardizes MRI procedures while significantly elevating efficiency. A notable feature includes the newly integrated SmartHeart, designed for complex cardiac planning. It can automatically generate plans from 3D survey images within a mere 30 seconds, accommodating unique facility angles for improved operator experience and reduced workload in cardiac MRI processing.
SmartSpeed Precise Dual AI Engine
Equipped with the advanced SmartSpeed Precise technology, the system can reduce imaging time by as much as 67% while enhancing image quality by up to 80%. This dual AI engine accomplishes what was previously thought unattainable: simultaneously shortening imaging durations without compromising picture clarity, thus enabling timely and precise diagnostic information delivery.
Enhancing Patient Experience
Smart Fit Coil
The BlueSeal series is designed with patient experience in mind, introducing the new Smart Fit Coil. This coil is not only lighter but also offers flexibility in setup, resulting in reduced preparation time for examinations. Such improvements minimize the burden on both patients and operators alike.
Advanced Cardiac Applications
Among the innovations, the BlueSeal series features cardiac applications, including Cine Free Breathing and Motion Correction. These tools significantly lower the chances of re-scanning for patients struggling with breath-holding, ultimately enhancing their overall experience. The newly developed quantitative techniques further offer substantial clinical benefits, ensuring optimal patient management during cardiac assessments.
As Philips Japan continues its mission to tackle healthcare challenges amidst a rapidly aging population, the BlueSeal series stands as a testament to its commitment to improving clinical workflows and enhancing patient outcomes through innovative technology. By merging artificial intelligence with advanced imaging capabilities, Philips is poised to redefine the future of MRI diagnostics, creating significant value in healthcare and beyond.
For more information about Philips Japan, please visit
Philips Japan.
About Philips
Royal Philips (NYSE:PHG, AEX:PHI), a leading health technology company, aims to improve people’s health and well-being through innovative technology. Established in 1953, the Japanese branch works toward advancing healthcare technology, contributing significantly to the nation's healthcare solutions.